Pharmafile Logo
Pharmafocus logo
Advanced Search
fda

FDA cautions that drug reviews will be slower due to COVID-19

April 17, 2020
Medical Communications COVID-19, FDA, coronavirus

The FDA has warned that they may not be able to sustain its current levels of timely reviews and approvals …

News
moderna-605x340

US Government’s BARDA to fund Moderna’s coronavirus vaccine by $483m

April 17, 2020
Medical Communications, Research and Development BARDA, COVID-19, Moderna, coronavirus, pharma

Moderna has secured $483 million in funding from the Biomedical Advanced Research and Development Authority (BARDA), to drive development and …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

April 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

Hydroxychloroquine dominates the news as the potential COVID-19 treatment has gone through various trials. A Chinese study showed that the …

News

Leaked data show Gilead’s remdesivir allows severe COVID-19 patients to be discharged after six days

April 17, 2020
Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir

The clinical benefit of Gilead’s promising antiviral therapy Remdesivir has been touted in the treatment of severe cases of COVID-19 …

News
inzulin

Governor of Minnesota signs emergency bill for insulin access

April 17, 2020
Medical Communications diabetes, insulin, insulin copays, medical insurance

Minnesota Governor Tim Walz has signed legislation to provide a one-time, 30-day supply of insulin for eligible residents in urgent …

News
aripiprazoleabilify

Clinical trial suggests new schizophrenia drug could reduce symptoms

April 16, 2020
Business Services D2, clinical trials, schizophrenia

Results from a newly published clinical trial suggest that a new compound could treat a broad range of schizophrenia symptoms. …

News
fda2outsideweb

FDA approves UroGen’s Jelmyto as first therapy for low-grade upper tract urothelial cancer

April 16, 2020
Sales and Marketing Cancer, FDA, Jelmyto, UroGen Pharma, pharma, urothelial cancer

The FDA has moved to authorise UroGen Pharma’s Jelmyto (mitomycin gel) in the US for the treatment of low-grade upper …

News
poshoo

New Chinese study shows Hydroxychloroquine does not speed up COVID-19 recovery

April 16, 2020
Business Services COVID-19, chloroquine, coronavirus, hydroxychloroquine

The anti-malaria drug hydroxychloroquine does not speed up recovery from COVID-19, according to a new Chinese study. The study was …

News
gilead-sciences

Gilead halts COVID-19 remdesivir trial due to enrolment issues, efficacy of the drug uncertain

April 16, 2020
Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

A clinical trial in China investigating Gilead’s antiviral therapy remdesivir as a potential treatment for COVID-19 has been placed on …

News
social_distancing

Intermittent social distancing could last until 2022, according to a new study

April 16, 2020
Business Services COVID, COVID-19, coronavirus, social distancing

Social distancing that has been put in place to stem the spread of COVID-19 coronavirus could be implemented up until …

News
nhs_sign_8

Scottish Medicines Consortium approves new drugs in multiple sclerosis, ulcerative colitis and diabetes

April 15, 2020
Research and Development, Sales and Marketing Biogen, Fambyra, Janssen, NHS, Rimzoic, Sandoz, Sanofi, Scotland, Scottish Medicines Consortium, Stelara, Suliqua, pharma

Medical regulation must still continue even in a global pandemic, and the Scottish Medicines Consortium, (SMC) has ploughed on with …

News
profileleee

Pharmafile.com’s weekly COVID-19 news round-up

April 15, 2020
Research and Development COVID-19, chloroquine, coronavirus, hydroxychloroquine

Hydroxychloroquine dominates the latest coronavirus news this week. The anti-malaria drug, touted by President Trump as an effective COVID-19 treatment, …

News
1_hpv_vaccine

COVID-19 puts more than 117 million children at risk of missing out on measles vaccines

April 15, 2020
Research and Development MMR vaccines, anti vaxx, anti-vaxx, anti-vaxxers, measles

Measles immunisation campaigns in 24 countries have been delayed due to COVID-19, threatening the vaccinations of 117 million Children. The …

News
shutterstock

Sanofi and GSK set aside rivalry with “unprecedented” COVID-19 vaccine partnership

April 15, 2020
Research and Development COVID-19, GSK, Sanofi, coronavirus

Usual rivals Sanofi and GlaxoSmithKline have said they are to put aside competition with the forging of a new “unprecedented …

News

US to suspend funding of the World Health Organization amidst review

April 15, 2020
Research and Development COVID, COVID-19, coronavirus

US President Donald Trump has announced the US will stop funding the World Health Organization due to allegations that they …

News
bristolll

Judge increases the amount of damages Gilead owes Bristol-Myers Squibb in CAR-T legal dispute

April 14, 2020
Manufacturing and Production Bristol-Myers Squibb, Gilead, bristol myers squibb

A judge has ruled that Gilead Sciences owe Bristol-Myers Squibb (BMS) additional funds after infringing on one of the company’s …

News

Patient Experience: Living with type 1 diabetes

April 14, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, diabetes, feature, patient experience

23-year-old US student Madelyn Lazra recently graduated with a BA in Business Law and certification in International Business, and is …

Feature
astrazeneca_building_white

AstraZeneca to pit blood cancer drug Calquence against COVID-19 with the company’s fastest-ever trial launch

April 14, 2020
Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Calquence, coronavirus, pharma

As the R&D race against COVID-19 continues, AstraZeneca is poised to launch a global, multicentre clinical trial to test its …

News
phone

UK to go ahead with COVID-19 contact-tracing app

April 14, 2020
Manufacturing and Production

The British government has confirmed it will go ahead in utilizing an app that will warn people if they have …

News
gilead-sciences

Gilead’s promising COVID-19 drug remdesivir shows benefit in 68% of hospitalised patients

April 14, 2020
Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead has provided an update on its ongoing efforts against the novel coronavirus, revealing data from a cohort analysis of …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026